Andrea C. Wasilewski, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5863

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Locations

Wilmot Cancer Institute Oncology
601 Elmwood Ave
Rochester, NY 14642-0001

Oncology: (585) 275-5823

Faculty Appointments

Assistant Professor - Department of Neurology , Neuro-Oncology (SMD)

Patient Care Setting

Neurology

Biography

Andrea Wasilewski MD is a board certified neurologist and neuro-oncologist with a passion for providing the highest quality patient care. She is also a clinical researcher and medical educator. Dr. Wasilewski specializes in treating patients with primary brain cancer, primary central nervous system lymphoma, brain metastases and neurologic complications of cancer. Her treatment philosophy emphasizes comprehensive and multifaceted approaches to cancer care for patients and their caregivers. As a clinical researcher Dr. Wasilewski develops and studies new ways of evaluating and treating older patients with brain cancer.

Credentials

Specialties

Neurology - General - American Board of Psychiatry and Neurology

Education

2014
MD | Jagiellonian University Medical College, Faculty of Medicine

Post-doctoral Training & Residency

07/01/2018 - 06/30/2019
Fellowship in Neuro-Oncology at University of Rochester Medical Center

06/10/2014 - 6/30/2015
Internship in Neurology at University of Rochester Medical Center

7/1/2015 - 6/30/2018
Residency in Neurology at University of Rochester Medical Center

VIEW ALL

Awards

2019
American Academy of Neurology Fellow Scholarship
Sponsor: American Academy of Neurology

Clinical Trials

Comprehensive Geriatric Assessment in Older Patients with Newly Diagnosed Malignant Gliomas

Lead Researcher: Andrea C Wasilewski

The purpose of this study is to collect information about the physical function, thinking, independence, social support, and medications of older patients with brain tumors in order to develop more specialized treatments and support for that population. Inclusion Criteria: Age 65 or older of any race, ethnicity, or gender; Pathologically confirmed glioblastoma or anaplastic astrocytoma; Have not started radiation or chemotherapy for brain tumor treatment

View Study Details

Publications

Journal Articles

9/1/2020
Saleh C, Jaszczuk P, Hund-Georgiadis M, Frank S, Cordier D, Bratic Hench I, Todea A, Wasilewski A, Wilmes S, Grigioni G, Hench J. "Differentiation of rare brain tumors through unsupervised machine learning: Clinical significance of in-depth methylation and copy number profiling illustrated through an unusual case of IDH wildtype glioblastoma." Clinical neuropathology.. 2020 Sep 1; Epub 2020 Sep 01.

7/13/2020
Wasilewski A, Alam A, Mohile N. "Chemotherapy toxicities and geriatric syndromes in older patients with malignant gliomas." Journal of geriatric oncology.. 2020 Jul 13; Epub 2020 Jul 13.

6/16/2020
Wasilewski A, Mohile N. "Meet the expert: How I treat chemotherapy-induced peripheral neuropathy." Journal of geriatric oncology.. 2020 Jun 16; Epub 2020 Jun 16.

VIEW ALL PUBLICATIONS

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates